Form 4: Berkshire Hathaway Sells Additional Shares of DaVita Inc. (DVA)
SEC Form 4
Berkshire Hathaway, along with Warren Buffett, reports the sale of additional DaVita Inc. shares between February 14 and February 19, 2025, reducing their indirect holdings.
Summary
- Berkshire Hathaway Inc. and Warren E. Buffett reported the sale of DaVita Inc. (DVA) common stock.
- The sales occurred between February 14, 2025, and February 19, 2025.
- The transactions involved multiple sales at varying prices.
- The prices ranged from approximately $150.12 to $159.19 on February 14, and from $153.00 to $156.02 between February 18 and 19.
- Berkshire Hathaway's indirect ownership in DaVita decreased as a result of these transactions.
- After the reported transactions, Berkshire Hathaway's indirect beneficial ownership stands at 35,142,479 shares.
Sentiment
Score: 3
Explanation: The sentiment is negative due to Berkshire Hathaway reducing its stake in DaVita, which could indicate a lack of confidence or a shift in investment strategy.
Negatives
- Berkshire Hathaway, a major shareholder, is reducing its stake in DaVita, which could be interpreted negatively by the market.
Risks
- Continued selling pressure from Berkshire Hathaway could further depress DaVita's stock price.
- The reasons behind Berkshire Hathaway's decision to sell shares are not disclosed, creating uncertainty.
Management Comments
- Warren E. Buffett disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Industry Context
Berkshire Hathaway's investment decisions are closely watched by the market, and their reduced stake in DaVita could influence investor sentiment towards the healthcare services sector.
Comparison to Industry Standards
- It's important to compare DaVita's performance and valuation metrics against its peers like Fresenius Medical Care to understand the implications of Berkshire's selling activity.
- Monitoring the trading activity of other major shareholders in DaVita and similar companies can provide further context.
Stakeholder Impact
- Shareholders may react negatively to the news of Berkshire Hathaway selling shares.
- The reduced stake could impact employee morale and confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Multiple sales of DaVita common stock occurred at prices ranging from $150.1200 to $159.1900. |
| 02/18/2025 | Multiple sales of DaVita common stock occurred at prices ranging from $153.1100 to $158.01. |
| 02/19/2025 | Multiple sales of DaVita common stock occurred at prices ranging from $153.0000 to $155.5600. |
Keywords
DaVita, Berkshire Hathaway, Warren Buffett, share sale, stock, DVA, holdings, transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.